Condition
Relapsed Pediatric ALL clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Relapsed Pediatric ALL clinical trials that are recruiting, at sites in 3 countries (most in China (2), United States (1), Canada (1)). By phase: Phase 1 (1), Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest Relapsed Pediatric ALL clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| CD19‑CAR T‑cell consolidation after TCRαβ/CD19‑depleted haploidentical family donor transplant for relapsed/refractory CD19+ B‑cell leukemia and lymphoma | Phase 1 | Memphis, Tennessee | Recruiting | Dec 2, 2025 |
| Evaluating CAR-T cell therapy with or without stem cell transplantation for relapsed B-cell leukemia | — | Beijing, Beijing Municipality | Recruiting | Aug 30, 2024 |
| Treatment of relapsed or refractory B-ALL in children and adolescents using pCAR-19B | Phase 2 | Beijing, Beijing Municipality and 15 other locations | Recruiting | Apr 19, 2022 |
| CAR T-cell therapy targeting CD19 for aggressive lymphoma and leukemia | Phase 1/2 | Calgary, Alberta and 5 other locations | Recruiting | May 6, 2019 |
All recruiting trials (4)
-
CD19‑CAR T‑cell consolidation after TCRαβ/CD19‑depleted haploidentical family donor transplant for relapsed/refractory CD19+ B‑cell leukemia and lymphoma
This will try giving CD19‑targeted CAR T cells shortly after a partially matched family‑donor transplant to children and young adults (≤21) with relapsed or refractory CD19+ B‑cell leukemia or lymphoma to see if the approach is safe and feasible.
-
Evaluating CAR-T cell therapy with or without stem cell transplantation for relapsed B-cell leukemia
This study tests if adding a stem cell transplant after CAR-T cell therapy can help young people with relapsed B-cell leukemia live longer and feel better.
-
Treatment of relapsed or refractory B-ALL in children and adolescents using pCAR-19B
This study is testing a new CAR T-cell therapy called pCAR-19B to see if it can help children and teens with hard-to-treat B-cell leukemia feel better.
-
CAR T-cell therapy targeting CD19 for aggressive lymphoma and leukemia
This study is testing a new type of treatment using modified immune cells to see if it can help people with aggressive lymphoma or leukemia that hasn't responded to other treatments.
Related topics
Quick answers
How many Relapsed Pediatric ALL clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (2 trials), United States (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.